Treating & caring for our queen of hearts
Women & heart disease
Webinar held on Tuesday, 15 August 2023 with an unrestricted educational grant from Biotronik and Cipla
This discussion focuses on women with established heart disease. It deals with when to refer patients to an interventional cardiologist for angioplasty and stenting, PCI, or other interventional procedures. The expected outcomes are also addressed, along with the post-intervention care needs of these patients.
Women and Cardiovascular Disease
A focus on heart failure
Webinar held on Thursday, 8 August 2023 with an unrestricted educational grant from Biotronik and Cipla
In this case study, we discuss a woman with early heart failure and identify missed opportunities in her care, such as hypertension management. We also focus on the next steps for this patient, presenting evidence for foundation medical therapy, pacing device intervention, and expected outcomes.
Managing LDL-cholesterol after a coronary event
Who gets therapy? Which agents should be considered and why? How to get greater clinician and patient buy-in?
Webinar held on Wednesday, 26 July 2023 with an unrestricted educational grant from Sanofi
The clinician addresses the LDL-cholesterol risk as part of post-cardiac event management, which is shown to significantly lower the risk of future CVD events. A patient case is used to explore opportunities for improving outcomes, introducing new therapies, and maintaining patient and clinician focus on lower LDL-cholesterol targets. Key clinical actions are defined and tailored to our local circumstances.
Anticoagulation in the patient with atrial fibrillation who suffers a stroke
When to start? Which agent should one select?
Webinar held on Thursday, 13 July 2023 with an educational grant from Sanofi
The clinician looking after a patient with AF relies on optimal use of laboratory data to select the best anti-coagulation options. Two case studies are presented to highlight the clinical issues and provide input from an expert haematologist. Every recommended therapeutic choice takes into account the relationship between diabetes and the heart.
The heart and diabetes
Is pre-diabetes a treatable entity?
Webinar held on Thursday, 22 June 2023 with an unrestricted educational grant from Cipla
Clinical action points are discussed in three patients needing care in early (pre-diabetes), intermediate and complicated T2DM. The relationship between diabetes and the heart informs every recommended therapeutic choice.